243 related articles for article (PubMed ID: 34041467)
1. A nationwide population-based prospective study of cirrhosis in Iceland.
Olafsson S; Rögnvaldsson S; Bergmann OM; Jonasson JG; Benitez Hernandez U; Björnsson ES
JHEP Rep; 2021 Jun; 3(3):100282. PubMed ID: 34041467
[TBL] [Abstract][Full Text] [Related]
2. Incidence of cirrhosis in Iceland-impact of the TraP HepC nationwide HCV elimination program.
Haraldsson HA; Olafsson S; Gottfredsson M; Benitez Hernandez U; Bjornsson ES
Scand J Gastroenterol; 2024 Apr; ():1-8. PubMed ID: 38676467
[TBL] [Abstract][Full Text] [Related]
3. Overview of Complications in Cirrhosis.
Premkumar M; Anand AC
J Clin Exp Hepatol; 2022; 12(4):1150-1174. PubMed ID: 35814522
[TBL] [Abstract][Full Text] [Related]
4. Liver cirrhosis in Iceland and Sweden: incidence, aetiology and outcomes.
Gunnarsdottir SA; Olsson R; Olafsson S; Cariglia N; Westin J; Thjódleifsson B; Björnsson E
Scand J Gastroenterol; 2009; 44(8):984-93. PubMed ID: 19437344
[TBL] [Abstract][Full Text] [Related]
5. Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study.
Vaz J; Eriksson B; Strömberg U; Buchebner D; Midlöv P
BMC Gastroenterol; 2020 Apr; 20(1):84. PubMed ID: 32245414
[TBL] [Abstract][Full Text] [Related]
6. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
[TBL] [Abstract][Full Text] [Related]
7. Diabetes and Hepatocellular Carcinoma: Incidence Trends and Impact of Liver Disease Etiology.
Doycheva I; Zhang T; Amjad W; Thuluvath PJ
J Clin Exp Hepatol; 2020; 10(4):296-303. PubMed ID: 32655232
[TBL] [Abstract][Full Text] [Related]
8. Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea.
Jang WY; Chung WJ; Jang BK; Hwang JS; Lee HJ; Hwang MJ; Kweon YO; Tak WY; Park SY; Lee SH; Lee CH; Kim BS; Kim SH; Suh JI; Park JG
J Korean Med Sci; 2020 Jul; 35(29):e233. PubMed ID: 32715667
[TBL] [Abstract][Full Text] [Related]
9. Natural History of Cirrhosis of Liver after First Decompensation: A Prospective Study in India.
Shah AS; Amarapurkar DN
J Clin Exp Hepatol; 2018 Mar; 8(1):50-57. PubMed ID: 29743797
[TBL] [Abstract][Full Text] [Related]
10. Effect of alcohol on clinical complications of hepatitis virus-induced liver cirrhosis: a consecutive ten-year study.
Abassa KK; Wu XY; Xiao XP; Zhou HX; Guo YW; Wu B
BMC Gastroenterol; 2022 Mar; 22(1):130. PubMed ID: 35305565
[TBL] [Abstract][Full Text] [Related]
11. NAFLD and MAFLD as emerging causes of HCC: A populational study.
Myers S; Neyroud-Caspar I; Spahr L; Gkouvatsos K; Fournier E; Giostra E; Magini G; Frossard JL; Bascaron ME; Vernaz N; Zampaglione L; Negro F; Goossens N
JHEP Rep; 2021 Apr; 3(2):100231. PubMed ID: 33748726
[TBL] [Abstract][Full Text] [Related]
12. Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease.
Antoury C; Lopez R; Zein N; Stoller JK; Alkhouri N
World J Hepatol; 2015 Jun; 7(10):1427-32. PubMed ID: 26052388
[TBL] [Abstract][Full Text] [Related]
13. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma in non-alcohol fatty liver disease - changing trends and specific challenges.
Berkan-Kawińska A; Piekarska A
Curr Med Res Opin; 2020 Feb; 36(2):235-243. PubMed ID: 31631714
[No Abstract] [Full Text] [Related]
15. Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis.
Frenette C; Kayali Z; Mena E; Mantry PS; Lucas KJ; Neff G; Rodriguez M; Thuluvath PJ; Weinberg E; Bhandari BR; Robinson J; Wedick N; Chan JL; Hagerty DT; Kowdley KV;
J Hepatol; 2021 Feb; 74(2):274-282. PubMed ID: 33038432
[TBL] [Abstract][Full Text] [Related]
16. Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis.
Jepsen P; Kraglund F; West J; Villadsen GE; Sørensen HT; Vilstrup H
J Hepatol; 2020 Nov; 73(5):1030-1036. PubMed ID: 32512015
[TBL] [Abstract][Full Text] [Related]
17. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.
Ioannou GN; Green P; Kerr KF; Berry K
J Hepatol; 2019 Sep; 71(3):523-533. PubMed ID: 31145929
[TBL] [Abstract][Full Text] [Related]
18. Development of severe alcohol related liver disease over four decades in Iceland: impact of increased access and use of alcohol.
Björnsson ES; Johannsson A; Sigurdarson SS; Hreinsson JP; Runarsdottir V
Scand J Gastroenterol; 2023; 58(12):1523-1533. PubMed ID: 37551903
[TBL] [Abstract][Full Text] [Related]
19. Hereditary hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer - nationwide population-based study.
Haider MB; Al Sbihi A; Chaudhary AJ; Haider SM; Edhi AI
World J Hepatol; 2022 Sep; 14(9):1804-1816. PubMed ID: 36185720
[TBL] [Abstract][Full Text] [Related]
20. Increase in the incidence of alcoholic pancreatitis and alcoholic liver disease in Iceland: impact of
Hauksson K; Arnardottir M; Agustsson AS; Magnusdottir BA; Baldursdottir MB; Lund SH; Kalaitzakis E; Björnsson ES
Scand J Gastroenterol; 2020 May; 55(5):615-620. PubMed ID: 32289240
[No Abstract] [Full Text] [Related]
[Next] [New Search]
